NEUROCRINE BIOSCIENCES INC — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+24.5% +$913M
$4.63B
Current Assets↑+46.3% +$798M
$2.52B
Cash & Equivalents↑+206.0% +$480M
$713M
ST Investments
—
Receivables↑+43.4% +$208M
$687M
Inventory↑+20.2% +$12M
$69M
Net PPE↑+8.7% +$7M
$90M
Goodwill
$6M
Intangibles↑+3.5% +$1M
$36M
Total Liabilities↑+22.1% +$249M
$1.38B
Current Liabilities↑+46.4% +$236M
$743M
Account Payables
—
Stockholders Equity↑+25.6% +$663M
$3.25B
Retained Earnings↑+1433.2% +$419M
$448M
Operating Lease ROU Asset↓-10.6% -$54M
$455M
Operating Lease Liability↑+3.6% +$16M
$471M
Gross PP&E↑+10.0% +$19M
$208M
Accumulated Depreciation↑+11.1% +$12M
$118M
Inventory Raw Materials↑+5.9% +$2M
$36M
Inventory WIP↑+76.1% +$8M
$19M
Inventory Finished Goods↑+11.7% +$2M
$14M